These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3291320)

  • 21. Cyclosporine in children.
    Polchi P; Lucarelli G; Galimberti M; Moretti L
    Prog Clin Biol Res; 1989; 309():333-48. PubMed ID: 2675102
    [No Abstract]   [Full Text] [Related]  

  • 22. Posttransplant risks of cyclosporine: Nephrotoxicity.
    Luke RG; Greifer I
    Am J Kidney Dis; 1985 Jun; 5(6):342-3. PubMed ID: 3893109
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term effects of short-term cyclosporine.
    Chapman JR; Morris PJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):186-91. PubMed ID: 3515686
    [No Abstract]   [Full Text] [Related]  

  • 24. [Side effects of cyclosporin following kidney transplantation and in patients with autoimmune diseases].
    von Graffenried B; Krupp P
    Internist (Berl); 1985 Sep; 26(9):542-8. PubMed ID: 3905674
    [No Abstract]   [Full Text] [Related]  

  • 25. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
    Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporine improves outcome in high-risk cadaveric renal allograft recipients.
    Van Buren CT; Flechner SM; Kerman RH; Vaughn W; Kahan BD
    Transplant Proc; 1984 Oct; 16(5):1162-6. PubMed ID: 6385365
    [No Abstract]   [Full Text] [Related]  

  • 27. Care of the renal transplant patient receiving cyclosporine.
    Oyler-Mooney J; Taylor S; Ulrich B
    J Nephrol Nurs; 1985; 2(6):274-6. PubMed ID: 3908647
    [No Abstract]   [Full Text] [Related]  

  • 28. Japanese Multicenter Trial of Cyclosporine in Renal Transplantation: overall results and analysis of the factors influencing graft survival rate.
    Ochiai T; Toma H; Takagi H; Oka T; Ishibashi M; Kashiwabara H; Fukao K; Ota K; Hashimoto I; Sonoda T
    Transplant Proc; 1987 Apr; 19(2):2961-6. PubMed ID: 3551242
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
    Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
    [No Abstract]   [Full Text] [Related]  

  • 30. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 31. The long-term effect of serum magnesium on cyclosporin A toxicity.
    Keven K; Canbakan B; Elhan AH
    Nephrol Dial Transplant; 2005 Dec; 20(12):2870. PubMed ID: 16169865
    [No Abstract]   [Full Text] [Related]  

  • 32. Preservation effect on oligo-anuria in the cyclosporine era: a prospective trial with 26 paired cadaveric renal allografts.
    Mendez R; Mendez RG; Koussa N; Cats S; Bogaard TP; Khetan U
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2047-50. PubMed ID: 3547908
    [No Abstract]   [Full Text] [Related]  

  • 33. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 34. Nephrotoxicity of cyclosporine in autoimmune diseases.
    Hannedouche TP; Delgado AG; Gnionsahe AD; Boitard C; Noël LH; Grünfeld JP
    Adv Nephrol Necker Hosp; 1990; 19():169-85. PubMed ID: 2105578
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporine-associated posttransplant hypertension incidence and effect on renal transplant function.
    Schorn T; Frei U; Brackmann H; Lorenz M; Vogt P; Wiese B; Pichlmayr R; Koch KM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):610-4. PubMed ID: 3291295
    [No Abstract]   [Full Text] [Related]  

  • 36. Morphology of cyclosporine nephrotoxicity in human heart transplant recipients.
    Chomette G; Auriol M; Beaufils H; Rottemburg J; Cabrol C
    J Heart Transplant; 1986; 5(4):273-8. PubMed ID: 3305818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
    Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
    J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine therapy and other adjuncts in the perioperative period with cadaveric and living related donor kidney transplantation.
    Milgrom M; Esquenazi V; Olson L; Fuller L; Roth D; Condie R; Kyriakides G; Miller J
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):8-11. PubMed ID: 3515699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.